27 Sep 2016 Date | | 0.1 Cons. EPS | 0.12 EPS |
26 Jul 2016 Date | | 0.15 Cons. EPS | 0.17 EPS |
29 Mar 2016 Date | | 0.03 Cons. EPS | 0.01 EPS |
5 Jan 2016 Date | | 0.06 Cons. EPS | 0.07 EPS |
29 Sep 2015 Date | | 0.13 Cons. EPS | 0.11 EPS |
27 Sep 2016 Date | | 0.1 Cons. EPS | 0.12 EPS |
26 Jul 2016 Date | | 0.15 Cons. EPS | 0.17 EPS |
29 Mar 2016 Date | | 0.03 Cons. EPS | 0.01 EPS |
5 Jan 2016 Date | | 0.06 Cons. EPS | 0.07 EPS |
29 Sep 2015 Date | | 0.13 Cons. EPS | 0.11 EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Albert Bolles CEO | NASDAQ (NGS) Exchange | 514766104 Cusip |
US Country | 689 Employees | - Last Dividend | - Last Split | - IPO Date |